Skip to main content

DVA

Stock
Health Care
Medical Care Facilities

Performance overview

DVA Price
Price Chart

Forward-looking statistics

Beta
0.60
Risk
34.07%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Company info

SectorHealth Care
IndustryMedical Care Facilities
Employees48K
Market cap$12.6B

Fundamentals

Enterprise value$24.5B
Revenue$13.0B
Revenue per employee—
Profit margin6.63%
Debt to equity742.20

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$10.08
Dividend per share—
Revenue per share$156.46
Avg trading volume (30 day)$118M
Avg trading volume (10 day)$140M
Put-call ratio—

Macro factor sensitivity

Growth+4.5
Credit+0.2
Liquidity-2.7
Inflation+1.3
Commodities+1.6
Interest Rates-0.1

Valuation

Dividend yield0.00%
PEG Ratio12.65
Price to sales0.83
P/E Ratio12.65
Enterprise Value to Revenue1.89
Price to book6.82

Upcoming events

Next earnings dayMay 13, 2025
Next dividend day—
Ex. dividend day—

News

Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research (July 10, 2025)
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space

An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.

Zacks Investment Research (July 2, 2025)
Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

CNBC (February 14, 2025)
Barclays' Andrew Mok: Any sustained underperformance in big tech will likely benefit healthcare

Andrew Mok, Barclays director of equity research, joins CNBC's 'The Exchange' to discuss why healthcare may offer opportunity as tech stocks are under pressure from China competition.

CNBC Television (January 28, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free